PL2215481T3 - Zastosowanie diagnostyczne indywidualnych postaci cząsteczkowych biomarkera - Google Patents

Zastosowanie diagnostyczne indywidualnych postaci cząsteczkowych biomarkera

Info

Publication number
PL2215481T3
PL2215481T3 PL08850368T PL08850368T PL2215481T3 PL 2215481 T3 PL2215481 T3 PL 2215481T3 PL 08850368 T PL08850368 T PL 08850368T PL 08850368 T PL08850368 T PL 08850368T PL 2215481 T3 PL2215481 T3 PL 2215481T3
Authority
PL
Poland
Prior art keywords
biomarker
diagnostic use
molecular forms
individual molecular
individual
Prior art date
Application number
PL08850368T
Other languages
English (en)
Other versions
PL2215481T5 (pl
Inventor
Lars Otto Uttenthal
Kristian Bangert
Original Assignee
Bioporto Diagnostics As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40260606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2215481(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioporto Diagnostics As filed Critical Bioporto Diagnostics As
Publication of PL2215481T3 publication Critical patent/PL2215481T3/pl
Publication of PL2215481T5 publication Critical patent/PL2215481T5/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL08850368T 2007-11-15 2008-11-14 Zastosowanie diagnostyczne indywidualnych postaci cząsteczkowych biomarkera PL2215481T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98813707P 2007-11-15 2007-11-15
EP08850368.5A EP2215481B2 (en) 2007-11-15 2008-11-14 Diagnostic use of individual molecular forms of a biomarker
PCT/DK2008/050274 WO2009062520A1 (en) 2007-11-15 2008-11-14 Diagnostic use of individual molecular forms of a biomarker

Publications (2)

Publication Number Publication Date
PL2215481T3 true PL2215481T3 (pl) 2014-08-29
PL2215481T5 PL2215481T5 (pl) 2017-10-31

Family

ID=40260606

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08850368T PL2215481T5 (pl) 2007-11-15 2008-11-14 Zastosowanie diagnostyczne indywidualnych postaci cząsteczkowych biomarkera

Country Status (7)

Country Link
US (2) US20100304413A1 (pl)
EP (1) EP2215481B2 (pl)
JP (1) JP2011503587A (pl)
CN (1) CN101910845A (pl)
ES (1) ES2475990T5 (pl)
PL (1) PL2215481T5 (pl)
WO (1) WO2009062520A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009246142A1 (en) 2008-05-15 2009-11-19 Transmolecular, Inc. Treatment of metastatic tumors
EP2344526A1 (en) 2008-11-05 2011-07-20 Abbott Laboratories Neutrophil gelatinase-associated lipocalin (ngal) protein isoforms enriched from urine and recombinant chinese hamster ovary (cho) cells and related compositions, antibodies, and methods of enrichment, analysis and use
RU2519722C2 (ru) * 2008-11-21 2014-06-20 Пхадиа Аб Способы, устройства и наборы для детекции или мониторинга острого повреждения почек
NZ702527A (en) * 2009-12-20 2016-07-29 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN106995493B (zh) 2010-02-04 2021-09-24 卫材公司 氯毒素多肽和结合物及其应用
ES2811065T3 (es) 2010-05-11 2021-03-10 Hutchinson Fred Cancer Res Variantes de clorotoxina, conjugados y métodos para su utilización
CA2804297A1 (en) 2010-06-23 2011-12-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP2014529073A (ja) * 2011-08-26 2014-10-30 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
US10935548B2 (en) 2011-12-08 2021-03-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
BR112015013515A2 (pt) 2012-12-10 2017-11-14 Hutchinson Fred Cancer Res métodos de geração de uma biblioteca de candidatos a fármaco definida por massa, e para identificar peptídeos possuindo uma propriedade farmacológica
EP3361255B1 (en) 2013-01-17 2020-03-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
WO2015084939A1 (en) 2013-12-03 2015-06-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3281011B1 (en) 2015-04-09 2024-06-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US11016099B2 (en) 2015-09-17 2021-05-25 Amgen Inc. Prediction of clinical response to IL23-antagonists using IL23 pathway biomarkers
US12048732B2 (en) 2016-04-15 2024-07-30 Blaze Bioscience, Inc. Methods of treating breast cancer
US11243217B2 (en) 2016-06-06 2022-02-08 Astute Medical, Inc. Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
CN105974128A (zh) * 2016-06-12 2016-09-28 吉林大学 一种人中性粒细胞载脂蛋白同源二聚体的定量装置
WO2018145117A1 (en) 2017-02-06 2018-08-09 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US11012774B2 (en) * 2018-10-29 2021-05-18 Apple Inc. Spatially biased sound pickup for binaural video recording
CN114402202A (zh) 2019-11-06 2022-04-26 Essenlix 公司 用于将非血体液中的生物标记物与血液中的生物标记物相关联的方法和装置
CN115480061A (zh) * 2021-05-31 2022-12-16 费森尤斯医疗护理德国有限责任公司 H-ngal用于检测腹膜炎
US20220026426A1 (en) * 2020-07-23 2022-01-27 Fresenius Medical Care Holdings, Inc. System for determining peritonitis using homodimer neutrophil gelatinase-associated lipocalin
JP2023537475A (ja) * 2020-08-03 2023-09-01 ナントセル，インコーポレーテッド Ｉｌ－１５スーパーアゴニストに対する薬物に特異的な薬物動態アッセイ
JP2022075614A (ja) * 2020-11-06 2022-05-18 徹 宮崎 遊離ａｉｍに特異的なモノクローナル抗体およびその利用
WO2024246048A1 (en) * 2023-06-01 2024-12-05 P & M Venge Ab Specific detection of homodimeric hnl
CN118666999B (zh) * 2024-06-27 2025-04-29 山东省大健康精准医疗产业技术研究院 一种中性粒细胞明胶酶相关脂质运载蛋白抗体及其制备方法与应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635091A (en) * 1970-08-31 1972-01-18 Frederick D Linzer Midstream urine specimen and fractional fluid collectors
IT1074038B (it) * 1976-08-05 1985-04-17 Simes Esteri della epinina
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
US4640909A (en) * 1985-05-07 1987-02-03 J. T. Baker Chemical Company Bonded phase of silica and carboalkoxyalkyl silanes for solid phase extraction
US5939272A (en) * 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
JP2912413B2 (ja) * 1990-03-28 1999-06-28 東亜医用電子株式会社 粒度分布作成方法
US5405832A (en) * 1991-11-27 1995-04-11 Immtech International Inc. Method of treating non-streptococcal bacterial infections
US5273961A (en) * 1992-09-22 1993-12-28 Genentech, Inc. Method of prophylaxis of acute renal failure
SE9401351D0 (sv) * 1994-04-21 1994-04-21 Venge A method for diagnosis
US5552313A (en) * 1994-11-21 1996-09-03 Kansas University DNA encoding mouse phosphotriesterase-related protein
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
US5627034A (en) * 1995-12-05 1997-05-06 Wisconsin Alumni Research Foundation Assay for carcinoma proliferative status by measuring NGAL expression level
US5821361A (en) * 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
EP1009762A2 (en) * 1997-08-06 2000-06-21 ZymoGenetics, Inc. Lipocalin homologs
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
AUPP784398A0 (en) * 1998-12-21 1999-01-21 Monash University Kidney disease detection and treatment
AU5330200A (en) * 1999-06-18 2001-01-09 Michigan State University Method and apparatus for the detection of volatile products in a sample
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
JP2004510981A (ja) * 2000-10-03 2004-04-08 ロウェット、リサーチ、インスティテュート ピロール含有生体化合物の測定方法およびピロール含有生体化合物
CA2425761C (en) * 2000-10-13 2005-11-15 Children's Medical Center Corporation Non-invasive enzyme screen for tissue remodelling-associated conditions
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20040203083A1 (en) * 2001-04-13 2004-10-14 Biosite, Inc. Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
EP1322957B1 (en) * 2001-05-04 2009-08-12 Biosite Incorporated Diagnostic markers of acute coronary syndromes and methods of use thereof
WO2003029462A1 (en) * 2001-09-27 2003-04-10 Pieris Proteolab Ag Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
US20030119209A1 (en) * 2001-12-21 2003-06-26 Kaylor Rosann Marie Diagnostic methods and devices
US6986995B2 (en) * 2002-02-28 2006-01-17 Prometheus Laboratories, Inc. Methods of diagnosing liver fibrosis
US6847451B2 (en) * 2002-05-01 2005-01-25 Lifescan, Inc. Apparatuses and methods for analyte concentration determination
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US7056702B2 (en) * 2002-12-16 2006-06-06 Kimberly Clark Co Detecting lipocalin
EP1616184B2 (en) * 2003-03-27 2018-05-30 Children's Hospital Medical Center A method and kit for detecting the early onset of renal tubular cell injury
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
WO2006066587A1 (en) * 2004-12-20 2006-06-29 Antibodyshop A/S Determination of neutrophil gelatinase-associated lipocalin (ngal) as a diagnostic marker for renal disorders
US20080050832A1 (en) * 2004-12-23 2008-02-28 Buechler Kenneth F Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
US20080090304A1 (en) * 2006-10-13 2008-04-17 Barasch Jonathan Matthew Diagnosis and monitoring of chronic renal disease using ngal
US20070196876A1 (en) * 2006-02-17 2007-08-23 Moses Marsha A Free NGAL as a biomarker for cancer
US20080061149A1 (en) * 2006-09-11 2008-03-13 Colin Tanner Proximity payment card with security interlock
US20090123970A1 (en) * 2007-10-19 2009-05-14 Abbott Laboratories Glycosylated mammalian ngal and use thereof
CA2702611A1 (en) † 2007-10-19 2009-04-23 Abbott Laboratories Immunoassays and kits for the detection of ngal
US20090124022A1 (en) * 2007-10-19 2009-05-14 Abbott Laboratories Antibodies that bind to mammalian ngal and uses thereof
US20090123946A1 (en) * 2007-10-19 2009-05-14 Abbott Laboratories Immunoassays and kits for the detection of ngal
US20090269777A1 (en) * 2007-10-19 2009-10-29 Abbott Laboratories Immunoassays and kits for the detection of ngal

Also Published As

Publication number Publication date
EP2215481A1 (en) 2010-08-11
EP2215481B1 (en) 2014-04-02
WO2009062520A1 (en) 2009-05-22
ES2475990T5 (es) 2017-07-06
JP2011503587A (ja) 2011-01-27
US20100304413A1 (en) 2010-12-02
PL2215481T5 (pl) 2017-10-31
CN101910845A (zh) 2010-12-08
ES2475990T3 (es) 2014-07-11
EP2215481B2 (en) 2017-01-18
US20130177923A1 (en) 2013-07-11

Similar Documents

Publication Publication Date Title
PL2215481T5 (pl) Zastosowanie diagnostyczne indywidualnych postaci cząsteczkowych biomarkera
GB2461448B (en) Transducer
AU310642S (en) Diagnostic meter
IL202451A0 (en) High-sensitvity pressure-sensing probe
GB0716672D0 (en) Laryngoscope
PL2208085T3 (pl) Pomiar oparty na funkcji szczegółowej
GB0712759D0 (en) Measuring pressure
TWI370413B (en) Graphical indicator
GB0700677D0 (en) Probe
AU312219S (en) Diagnostic meter
IL199807A0 (en) Biometric diagnosis
GB0724020D0 (en) An instrument
GB0716202D0 (en) Improved fluid probe
EP2324353A4 (en) TRANSDUCER MICROARRAY FUNCTIONALIZED SELECTIVELY
GB0823616D0 (en) Instrument
EP2239543A4 (en) INSTRUMENT OF INDICATION
GB2458124B (en) Indicator
GB0708411D0 (en) Lanthanide probes
GB0701401D0 (en) Indicator
GB2448742B (en) Indicator
TWI339731B (en) Probe assembly
HU0700126V0 (en) Self-alertness tester
PL117136U1 (pl) Twardościomierz
GB0809377D0 (en) Diagnostic marker
GB0809376D0 (en) Diagnostic marker